Cao et al. found that NKX2-2-AS1 was highly expressed in Ewing sarcomas, functioning as a core co-regulator of the driver mutation fusion gene, and is recognized as a specific biomarker for Ewing sarcomas [26]. This evidence concerns the gene NKX2-2 and Ewing sarcoma.